Blood cancers

Monitoring of multiple myeloma out of step with international practice

International consensus criteria for the assessment of response and minimal residual disease in multiple myeloma may be ahead of clinical practice in Australia. Dr Louise Wienholt, from the Royal College of Pathologists of Australasia’s (RCPA) Quality Assurance Program, told the limbic that there was too much variability between laboratories in Australia with respect to tests ...

Already a member?

Login to keep reading.

© 2021 the limbic